Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
- Overview
- Culture and Benefits
Contact

Press Releases

Year

August 3, 2023

Longboard Pharmaceuticals to Present at Upcoming Investor Conferences

June 26, 2023

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023

May 9, 2023

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

April 11, 2023

Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

March 2, 2023

Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives

February 23, 2023

Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

February 10, 2023

Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock

February 7, 2023

Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock

February 7, 2023

Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 19 of 19

©2023 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
- Overview
- Culture and Benefits
Contact